MedDataX Logo

Prophylaxis of Ventilator Associated Pneumonia by Continuous Lateral Rotation Therapy

NCT ID: NCT00529776

Last Updated: 2008-06-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-09-30

Study Completion Date

2008-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hypothesis: Ventilator associated pneumonia (VAP) in critically ill patients may be prevented by continuous lateral rotation therapy (CLRT) using specially designed, motor driven beds.

Patients are randomized to CLRT or supine position if mechanically ventilated and not suffering from pneumonia or ARDS within 48 hours after intubation. Prophylaxis of VAP is standardized in both groups. Primary endpoint is incidence of VAP, secondary endpoints are length of ventilation, length of stay and mortality.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pneumonia, Ventilator-Associated

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Prevention of ventilator associated pneumonia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Continuous lateral rotation therapy

Group Type ACTIVE_COMPARATOR

Continuous lateral rotation therapy

Intervention Type PROCEDURE

2

Standard manual positioning (Supine position)

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Continuous lateral rotation therapy

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Mechanically ventilated
* Intubated not longer than 48 h
* Medical cause for ICU admission
* Expected to be ventilated for \> 48 hours

Exclusion Criteria

* Pneumonia or ARDS present
* Postoperative patient
Minimum Eligible Age

18 Years

Maximum Eligible Age

89 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medical University of Vienna

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Medical University of Vienna

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thomas Staudinger, MD

Role: PRINCIPAL_INVESTIGATOR

Department of Internal Medicine I, Medical University of Vienna, Austria

Thomas Staudinger, MD

Role: PRINCIPAL_INVESTIGATOR

Dept. of Internal Medicine I, Medical University of Vienna

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Vienna General Hospital, Medical University of Vienna

Vienna, , Austria

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EK 38/2004

Identifier Type: -

Identifier Source: org_study_id